Key result
Trypanosoma cruzi infection alters cardiac fibroblast IL-6 signaling via inverse host piRNA expression changes.
Why the study?
The molecular mechanisms by which Trypanosoma cruzi induces cardiopathogenesis remain to be determined, including the role of IL-6 signaling during early infection.
Does Trypanosoma cruzi infection dysregulate IL-6 signaling molecules and targeted piRNAs in primary human cardiac fibroblasts?
Does Trypanosoma cruzi infection dysregulate IL-6 signaling molecules and targeted piRNAs in primary human cardiac fibroblasts?
Answers are grounded in this paper and cite their sources.
This study identifies specific piRNAs as novel regulators of the IL-6 signaling pathway during early T. cruzi infection, highlighting potential therapeutic targets for mitigating Chagasic cardiomyopathy.
Trypanosoma cruzi, the etiological agent of Chagas disease, is an intracellular protozoan parasite, which is now present in most industrialized countries. About 40% of T. cruzi infected individuals will develop severe, incurable cardiovascular, gastrointestinal, or neurological disorders. The molecular mechanisms by which T. cruzi induces cardiopathogenesis remain to be determined. Previous studies showed that increased IL-6 expression in T. cruzi patients was associated with disease severity. IL-6 signaling was suggested to induce pro-inflammatory and pro-fibrotic responses, however, the role of this pathway during early infection remains to be elucidated. We reported that T. cruzi can dysregulate the expression of host PIWI-interacting RNAs (piRNAs) during early infection. Here, we aim to evaluate the dysregulation of IL-6 signaling and the piRNAs computationally predicted to target IL-6 molecules during early T. cruzi infection of primary human cardiac fibroblasts (PHCF). Using in silico analysis, we predict that piR_004506, piR_001356, and piR_017716 target IL6 and SOCS3 genes, respectively. We validated the piRNAs and target gene expression in T. cruzi challenged PHCF. Secreted IL-6, soluble gp-130, and sIL-6R in condition media were measured using a cytokine array and western blot analysis was used to measure pathway activation. We created a network of piRNAs, target genes, and genes within one degree of biological interaction. Our analysis revealed an inverse relationship between piRNA expression and the target transcripts during early infection, denoting the IL-6 pathway targeting piRNAs can be developed as potential therapeutics to mitigate T. cruzi cardiomyopathies.
No takes yet. Share an insight, caveat, or question.
Cooley et al. (2022) studied Chagas disease cardiomyopathy (in vitro model). Trypanosoma cruzi infection vs. Uninfected control cells was evaluated on Dysregulation of IL-6 signaling pathway and targeted piRNAs. Infection of primary human cardiac fibroblasts with Trypanosoma cruzi induced an inverse relationship between the expression of specific host piRNAs and their target transcripts IL-6 and SOCS3, leading to altered IL-6 pathway activation.
Synapse has enriched 10 related papers. Consider them for comparative context: